Reticular Embryo Analysis

Drug discovery and biotech · by Reticular

Reanalyzes existing PGT-A embryo data across all embryos and all cycles for a flat fee, screening 500+ pregnancy-loss genes and reporting lifelong health risk across 24+ conditions. Reports include genetic counselor review and are intended for discussion with a care team; the service does not diagnose conditions or guarantee outcomes.

What it does

Reanalyzes existing PGT-A embryo data across all embryos and all cycles for a flat fee, screening 500+ pregnancy-loss genes and reporting lifelong health risk across 24+ conditions. Reports include genetic counselor review and are intended for discussion with a care team; the service does not diagnose conditions or guarantee outcomes.

  • Embryo genetic screening
  • IVF risk reporting
  • Infertility and pregnancy loss gene screening
Category
Drug discovery and biotech
Built for
Healthcare and life sciences
Users
Patients trying to conceive, IVF patients
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

  • One-time$1,000
    • Fee · all embryos
    • All cycles
    • No per-embryo pricing

Prices as published by Reticular, checked Oct 2026.

Security and compliance

As reported by Reticular. Ask for audit reports before you buy.

  • encryption_at_rest
  • encryption_in_transit

Reviews

No reviews yet

Reviews come from people who use Reticular Embryo Analysis at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim Reticular Embryo Analysis